Lonza launches AI-enabled Route Scouting Service to accelerate small molecule development
New advanced technology-enabled offering aims to streamline synthetic route identification for novel active pharmaceutical ingredients (APIs)
New advanced technology-enabled offering aims to streamline synthetic route identification for novel active pharmaceutical ingredients (APIs)
Before joining Gland, Loomba was associated with Shalina Labs, Harman Finochem, Aurobindo Pharma, Sun Pharmaceuticals and Ranabaxy Laboratories.
New solvent-free micronization technology expanded at the Darmstadt site in Germany
The Gold Medal distinction places the company in the top 5% of all organizations assessed within EcoVadis's rigorous framework globally
Aims to become a leading global partner for botanical extracts and natural actives in the beauty and personal care market
Highly effective preservation solutions ensuring the safety and protection of personal care products
Aurigene.AI is an end-to-end solution for small molecule drug discovery
Utidelone has the ability to cross BBB due to its unique physicochemical characteristic and insusceptibility to P-glycoprotein-mediated efflux
Additional capacity broadens Grace’s fine chemical capabilities for API production
Subscribe To Our Newsletter & Stay Updated